articleThe LancetJun 1, 2008Closed access

Treatment of patients with mildly symptomatic pulmonary arterial hypertension with bosentan (EARLY study): a double-blind, randomised controlled trial

University of Bologna · University of California, San Diego · +7 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

No abstract available for this paper.

Citation impact

915
total citations
FWCI
64.81
Percentile
100%
References
31
Citations per year

Authors

9

Topics & keywords

Keywords
  • Bosentan
  • Medicine
  • Internal medicine
  • Pulmonary hypertension
  • Double blind
  • Randomized controlled trial
  • Cardiology
  • Endothelin receptor
UN Sustainable Development Goals
  • Good health and well-being
No related works found for this paper.

Funding